![Charles Berkman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Berkman
Direktor/Vorstandsmitglied bei
PFENEX INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Charles Stuart Berkman is Secretary, Director, Senior VP & General Counsel at Pelican, Inc. since 2020.
Holds positions as Secretary & Director at Ligand UK Group Ltd., Secretary & Vice President at Metabasis Therapeutics, Inc. since 2010, Secretary & Chief Legal Officer at OmniAb Operations, Inc. since 2022, and Secretary & Chief Legal Officer at OmniAb, Inc. since 2022.
Formerly Secretary & Director at Ligand UK Research Ltd. and Ligand UK Ltd. from 2018 to 2022.
Served as Secretary, Senior Vice President & General Counsel at Ligand Pharmaceuticals, Inc. from 2001 to 2022.
Worked as Attorney at Baker & McKenzie LLP (Illinois) from 2000 to 2001 and at Lyon & Lyon, Inc. from 1993 to 2000.
Completed undergraduate studies at The University of Texas at Austin and graduate studies at The University of Texas School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMNIAB, INC. 0,28 % | 23.04.2026 | 399.085 ( 0,28 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Charles Berkman
| Unternehmen | Position | Beginn |
|---|---|---|
| PFENEX INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| OMNIAB, INC. | General Counsel | 01.03.2022 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Unternehmenssekretär | 29.01.2010 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 12.10.2018 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | General Counsel | 01.03.2022 |
Ehemalige bekannte Positionen von Charles Berkman
| Unternehmen | Position | Ende |
|---|---|---|
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 19.03.2024 |
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 01.11.2022 |
| VERNALIS | Direktor/Vorstandsmitglied | 01.11.2022 |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.11.2001 |
| ░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Charles Berkman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
The University of Texas School of Law
 The University of Texas School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
